Although classical dopaminergic markers (TH, SLC6A3, DRD1–5) were not detected in the serum-derived transcriptomes, the identified hub genes may still affect dopaminergic function indirectly by modulating metabolic, oxidative stress, and inflammatory/coagulation pathways, thereby influencing MDD susceptibility. This evidence concerns the gene DRD1 and major depressive disorder.